GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
299 hedge funds and large institutions have $3.08B invested in GW Pharmaceuticals Plc American Depositary Shares in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 66 increasing their positions, 99 reducing their positions, and 37 closing their positions.
38% more capital invested
Capital invested by funds: $2.23B → $3.08B (+$844M)
30% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 37
3% more funds holding
Funds holding: 289 → 299 (+10)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
33% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 99
33% less call options, than puts
Call options by funds: $57M | Put options by funds: $85.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$82.3M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$49.9M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$18.2M |
| 4 |
Bank of New York Mellon
New York
|
+$13.5M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$83.8M |
| 2 |
MGIM
M&G Investment Management
London,
United Kingdom
|
-$31.2M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$31.1M |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$21.1M |
| 5 |
Holocene Advisors
New York
|
-$18.1M |
GWPH Hedge Fund Activity: Q2 2020 in Review
299 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2020, worth a combined $3.08B — up 38% from $2.23B a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new GWPH positions and 37 closed out — a net gain of 11 holders — while 66 added to existing stakes and 99 trimmed.
The largest buyer was Capital World Investors, adding an estimated $82.3M. The largest seller was Victory Capital Management, cutting an estimated $83.8M.
- 299 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2020, up from 289 in Q1 2020.
- Funds reported $3.08B of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2020, up 38% quarter-over-quarter.
- 48 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2020 and 37 closed out, a net change of +11 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q2 2020 was Capital World Investors, an estimated $82.3M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2020 was Victory Capital Management, an estimated $83.8M sold.
Based on aggregated 13F filings for Q2 2020.